Application Information

This drug has been submitted to the FDA under the reference 078804/001.

Names and composition

"ASPIRIN AND DIPYRIDAMOLE" is the commercial name of a drug composed of ASPIRIN and DIPYRIDAMOLE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
078804/001 ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE/ORAL 25MG and 200MG
206392/001 ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE/ORAL 25MG and 200MG
206739/001 ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE/ORAL 25MG and 200MG
206964/001 ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE/ORAL 25MG and 200MG
207944/001 ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE/ORAL 25MG and 200MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
020884/001 AGGRENOX ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE/ORAL 25MG and 200MG
078804/001 ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE/ORAL 25MG and 200MG
206392/001 ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE/ORAL 25MG and 200MG
206739/001 ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE/ORAL 25MG and 200MG
206964/001 ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE/ORAL 25MG and 200MG
207944/001 ASPIRIN AND DIPYRIDAMOLE ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE/ORAL 25MG and 200MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved